Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vertex's Sales Plunge 64% as It Refocuses Its Pipeline on Cystic Fibrosis Therapies
Vertex's Sales Plunge 64% as It Refocuses Its Pipeline on Cystic Fibrosis Therapies
Vertex's Sales Plunge 64% as It Refocuses Its Pipeline on Cystic Fibrosis Therapies
Submitted by
admin
on May 1, 2014 - 10:15pm
Source:
Motley Fool
News Tags:
cystic fibrosis
Vertex Pharmaceuticals
hepatitis C
earnings
Headline:
Vertex's Sales Plunge 64% as It Refocuses Its Pipeline on Cystic Fibrosis Therapies
Do Not Allow Advertisers to Use My Personal information
